Published in Biochem Soc Trans on June 01, 1980
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med (2001) 24.51
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med (1996) 13.49
Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther (2000) 5.09
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res (1996) 3.77
Incidence of malignant tumors in U. S. children. J Pediatr (1975) 3.01
Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest (2000) 2.90
Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst (1984) 2.52
CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood (1997) 2.37
Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79. J Natl Cancer Inst (1983) 2.08
Childhood cancer. Cancer (1995) 2.05
Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst (1987) 2.02
Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer (1986) 1.93
Retracted Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci U S A (1995) 1.93
Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J Biol Chem (1995) 1.81
Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise. Arch Intern Med (1974) 1.76
Stimulation tests of pituitary-Leydig cell function in normal male subjects and hypogonadal men. Clin Endocrinol (Oxf) (1972) 1.58
Rates, interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. J Natl Cancer Inst (1968) 1.52
Time required for complete recovery from chronic propranolol therapy. N Engl J Med (1973) 1.51
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis. Blood Cells Mol Dis (1997) 1.34
Cancer incidence and mortality in the United States, 1973-77. Natl Cancer Inst Monogr (1981) 1.31
Assessing the validity of observed cancer incidence trends. Am J Epidemiol (1984) 1.28
Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther (2003) 1.25
The structure-based design of ATP-site directed protein kinase inhibitors. Curr Med Chem (1999) 1.22
An analysis of the therapeutic elements in a black church service. Hosp Community Psychiatry (1984) 1.19
Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law (1986) 1.18
Recent trends in cervix uteri cancer. Cancer (1989) 1.18
Uptake and incorporation of glucose and mannose by whole cells of Bacteroides thetaiotaomicron. Appl Environ Microbiol (1977) 1.16
Discharge properties of hindlimb motoneurons in decerebrate cats during locomotion induced by mesencephalic stimulation. J Neurophysiol (1980) 1.11
Incidence of the histologic types of ovarian cancer: the U.S. Third National Cancer Survey, 1969-1971. Gynecol Oncol (1977) 1.08
Dr Thomas Beddoes and James Watt: preparatory work 1794-96 for the Bristol Pneumatic Institute. Med Hist (1986) 1.08
Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience. J Natl Cancer Inst (1984) 1.08
Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus. J Cell Biochem (1992) 1.06
Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. J Biol Chem (1990) 1.05
Gene transfer to intact mesenteric arteries by electroporation. J Vasc Res (2000) 1.04
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Clin Cancer Res (1998) 1.02
Retracted 4,5-Dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc Natl Acad Sci U S A (1994) 1.01
Psychological benefits of Spiritual Baptist "mourning," II: An empirical assessment. Am J Psychiatry (1986) 0.97
Molecular cloning and characterization of a negative-acting nitrogen regulatory gene of Neurospora crassa. Mol Gen Genet (1988) 0.97
A national quality improvement effort: cancer registry data. J Surg Oncol (1995) 0.96
Race, neighbourhood characteristics and disparities in chemotherapy for colorectal cancer. J Epidemiol Community Health (2009) 0.96
Physiological alterations of motor units in hemiplegia. J Neurol Sci (1982) 0.96
Lactate accumulation relative to the anaerobic and respiratory compensation thresholds. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.95
Two methods for the separation of human alpha-fetoprotein and albumin. (A) Affinity chromatography using Blue Sepharose CL-6B and (B) ampholyte displacement chromatography. Anal Biochem (1978) 0.95
T cell responses to heat-shock protein 60: differential responses by CD4+ T cell subsets according to their expression of CD45 isotypes. J Immunol (1999) 0.95
Cancer incidence in Jewish migrants to Israel, 1961-1981. IARC Sci Publ (1989) 0.95
Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer (1999) 0.94
The entry of ascorbic acid into the corpus luteum in vivo and in vitro and the effect of luteinizing hormone. J Endocrinol (1967) 0.93
Properties of stimulus trains producing maximum tension-time area per pulse from single motor units in medial gastrocnemiu muscle of the cat. J Neurophysiol (1980) 0.91
Structure and provision of services in Black churches in New Haven, Connecticut. Cultur Divers Ethnic Minor Psychol (1999) 0.91
Phenylamino-pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC). Arch Pharm (Weinheim) (1996) 0.90
Minoxidil in severe hypertension: value when conventional drugs have failed. Am Heart J (1975) 0.90
Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain. J Biol Chem (1996) 0.89
Incidence of cancer in United States blacks. Cancer Res (1975) 0.88
Use of a competitive protein-binding assay for adenosine 3':5'-phosphate for the study of bovine corpus luteum adenylate cyclase. J Endocrinol (1977) 0.88
Endodermal sinus tumour of the ovary: serum alpha-fetoprotein levels before and after treatment and during pregnancy. Case report. Br J Obstet Gynaecol (1980) 0.88
Plasma lactate and ventilation thresholds in trained and untrained cyclists. J Appl Physiol (1985) (1986) 0.88
Adaptation in human subjects to the effects of inhaled ozone after repeated exposure. Am Rev Respir Dis (1979) 0.87
Immunochemical mapping of alpha-2 interferon. Biochemistry (1985) 0.87
Murine T cells reactive against autologous erythrocytes: evidence for in vitro and in vivo priming with mouse and rat red blood cells. Cell Immunol (1987) 0.86
Marital status and incidence of ovarian cancer: the U.S. Third National Cancer Survey, 1969--71. J Natl Cancer Inst (1977) 0.86
Cholesteryl esterase and cholesteryl ester pools in corpus luteum. J Lipid Res (1968) 0.86
Uterine cancers of unspecified origin--a reassessment. Public Health Rep (1983) 0.85
Emotional disturbance following childbirth: clinical findings and urinary excretion of cyclic AMP (adenosine 3'5'cyclic monophosphate). Psychol Med (1979) 0.85
Cancer registration in the Middle East. Epidemiology (2001) 0.85
Follow-up study of patients with benign mucosal polyps discovered by proctosigmoidoscopy. Dis Colon Rectum (1974) 0.84
Recurrent self-injurious behavior in forensic patients. Psychiatr Q (1996) 0.84
Effect of polymorphism of the HLA-DPA1 chain on presentation of antigenic peptides. Hum Immunol (1997) 0.83
Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors. Eur J Biochem (1992) 0.83
Cdc2-mediated modulation of pp60c-src activity. J Biol Chem (1994) 0.82
Proceedings: Solubilization of adenylate cyclase of rat corpora lutes. Biochem Soc Trans (1974) 0.82
Anti-ketogenic effect of glucose in the lactating cow deprived of food. Biochem J (1976) 0.82
Subjective, laryngoscopic, and acoustic measurements of laryngeal reflux before and after treatment with omeprazole. J Voice (1996) 0.82
Structures of staurosporine bound to CDK2 and cAPK--new tools for structure-based design of protein kinase inhibitors. Structure (1997) 0.81
Cancer. Introduction. Cancer (1995) 0.81
Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src. Oncogene (1999) 0.81
Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-src tyrosine protein kinase activity. Anal Biochem (1992) 0.81
Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients. Ann Rheum Dis (1998) 0.81
Evidence for an essential role for high-density lipoprotein in progesterone synthesis by rat corpus luteum. FEBS Lett (1981) 0.81
Inotropic effects of tolbutamide in man. Am Heart J (1975) 0.81
Endogenous phosphorylation of microsomal proteins in bovine corpus luteum. Tenfold activation by adenosine 3':5'-cyclic monophosphate. Biochem J (1977) 0.81
Concentrations of immunoreactive thyrotrophic hormone in urine of normal subjects, patients with thyroid disorders and hypopituitarism, and after infusion of human thyrotrophic hormone. J Endocrinol (1974) 0.81
Solubilization of bovine corpus-luteum adenylate cyclase in lubrol-PX, triton X-100 or digitonin and the stabilizing effect of sodium fluoride present in the solubilization medium. Biochem J (1978) 0.79
Proceedings: Rat luteal adenosine 3':5'-cyclic monophosphate-dependent protein kinase. Biochem Soc Trans (1974) 0.79
A comparison of population-based cancer incidence rates in Israel and Jordan. Eur J Cancer Prev (2003) 0.79
American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #4: Clinical research implications. Cancer (1993) 0.78
Impaired intestinal absorption of glucose in 4 foals with Lawsonia intracellularis infection. J Vet Intern Med (2009) 0.78
Treadmill walking protocol for the diagnostic evaluation and exercise programming of cardiac patients. Am J Cardiol (1983) 0.78
Activation of adenylate cyclase in bovine corpus-luteum membranes by human choriogonadotropin, guanine nucleotides and NaF. Biochem J (1981) 0.78
Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis. J Urol (1993) 0.78
Serum insulin, glucose, and lipid levels among mild diabetics in relation to incidence of vascular complications. Lancet (1971) 0.77
Paeciloquinones A, B, C, D, E and F: new potent inhibitors of protein tyrosine kinases produced by Paecilomyces carneus. I. Taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) (1995) 0.77
Hormonal activation of bovine luteal adenylate cyclase [proceedings]. Biochem Soc Trans (1979) 0.77
Benzopyranones and benzothiopyranones: a class of tyrosine protein kinase inhibitors with selectivity for the v-abl kinase. Cancer Res (1992) 0.77